CADL
Candel Therapeutics·NASDAQ
--
--(--)
--
--(--)
CADL fundamentals
Candel Therapeutics (CADL) released its earnings on Aug 14, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.09 (YoY +87.84%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.09
+87.84%
Report date
Aug 14, 2025
Earnings Call
8:00 AM on Aug 12, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Candel Therapeutics (CADL) key financial stats and ratios, covering profitability, financial health, and leverage.
Candel Therapeutics (CADL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Candel Therapeutics (CADL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Candel Therapeutics (CADL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Candel Therapeutics (CADL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Candel Therapeutics (CADL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Candel Therapeutics do and what are its main business segments?What factors drove the changes in Candel Therapeutics's revenue and profit?Did Candel Therapeutics beat or miss consensus estimates last quarter?What is Candel Therapeutics's gross profit margin?What is Candel Therapeutics's latest dividend and current dividend yield?What is the market's earnings forecast for Candel Therapeutics next quarter?What were the key takeaways from Candel Therapeutics's earnings call?What were the key takeaways from Candel Therapeutics’s earnings call?
